Skip to main content
SpringerLink
Log in

Optimization of growth hormone therapy in growth hormone deficient children

  • International Symposium on Recent Advances in Growth Hormone Replacement Therapy
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Conclusion

It is obvious that the results published so far as well as the present preliminary data do not answer many questions regarding the optimal therapeutic regimen in GH deficiency. In particular, long-term follow-up must be organized to evaluate efficacy and safety of GH therapy not only in GHD but also for the “new” indications such as Turner syndrome, short stature without classical GH deficiency and chronic renal failure.

Finally the high expectations and the high costs of longterm GH treatment should receive full consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Raben MS. Treatment of a pituitary dwarf with human growth hormone.J Clin Endocrinol 1958; 18: 901–903.

    CAS  Google Scholar 

  2. Ranke M, Weber B, Bierich JR. Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency.Eur J Pediatr 1979; 132: 221–238.

    Article  PubMed  CAS  Google Scholar 

  3. Burns EC, Tanner JM, Preece MA, Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone.Eur J Pediatr 1981; 137: 155–164.

    PubMed  CAS  Google Scholar 

  4. Joss E, Zuppinger K, Schwarz HP, Roten H. Final height of patients with pituitary growth failure and changes in growth variables after long tern hormonal therapy.Pediatr Res 1983; 17: 676–679.

    Article  PubMed  CAS  Google Scholar 

  5. Bundak R, Hindmarsh PC, Smith PJ, Brook CGD. Long-term auxologic effects of human growth hormone.J Pediatr 1988; 112: 875–879.

    Article  PubMed  CAS  Google Scholar 

  6. Hibi I, Tanaka T and Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation, Japan. Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment.Acta Endocrinol (Copenh) 1989; 120: 409–415.

    CAS  Google Scholar 

  7. Darendeliler F, Hindmarsh PC, Brook CGD. Dose-response curves for treatment with biosynthetic human growth hormone.J Endocrinol 1990; 125: 311–316.

    PubMed  CAS  Google Scholar 

  8. Bourguignon JP, Vandeweghe M, Vanderschueren-Lodeweyckx M et al. Pubertal growth and final height in hypopitiutary boys: A minor role of bone age at onset of puberty.J Clin Endocrinol Metab 1986; 63: 376–382.

    PubMed  CAS  Google Scholar 

  9. Trygstad O. Human growth hormone and hypopituitary growth retardation.Acta Peadiatr Scand 1969; 58: 407–419.

    CAS  Google Scholar 

  10. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.Arch Dis Child 1971; 46: 745–782.

    PubMed  CAS  Google Scholar 

  11. Frasier SD, Aceto T, Hayles AB, Mikity VG. Collaborative study of the effect of human growth hormone in growth hormone deficiency: IV. Treatment with low doses of human growth hormone based on body weight.J Clin Endocrinol Metab 1977; 44: 22–31.

    PubMed  CAS  Google Scholar 

  12. Verbeek JHAM, Steendijk R, Bot A, Van der Werff ten Bosch JJ. Langdurige behandeling van hypofysaire groeistoornissen met menselijk groeihormoon; resultaten bij 38 Nederlandse kinderen.Ned Tijdschr Geneeskd 1979; 13: 510–520.

    Google Scholar 

  13. Preece MA, Tanner JM, Whitehouse RH, Cameron N. Dose dependence of growth response to human growth hormone deficiency.J Clin Endocrinol Metab 1976; 43: 477–483.

    Google Scholar 

  14. Frasier SD, Costin G, Lippe BM et al. A dose-response curve for human growth hormone.J Clin Endocrinol Metab 1981; 53: 1213–1217.

    Article  PubMed  CAS  Google Scholar 

  15. Vicens-Calvet E, Vendrell JM, Albisu M et al. The dosage dependency of growth and maturity in growth hormone deficiency treated with human growth hormone.Acta Paediatr Scand 1984; 73: 120–126.

    PubMed  CAS  Google Scholar 

  16. Job JC, Chaussain JL, Garnier P et al. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.Acta Paediatr Scand 1987; 337: 93–105.

    CAS  Google Scholar 

  17. Rosenbloom AL, Knuth CL. Growth response in growth hormone-deficient patients to 0.06 mg/kg compared with 0.10 mg/kg three time per week of biosynthetic growth hormone.Am J Dis Child 1989; 143: 642–643.

    PubMed  CAS  Google Scholar 

  18. Jansson JO, Albertsson-Wikland K, Eden S et al. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.Acta Physiol Scand 1982; 114: 261–265.

    Article  PubMed  CAS  Google Scholar 

  19. Jansson JO, Albertsson-Wikland K, Eden S et al. Circumstantial evidence for a role of the secretory pattern of growth hormone in control of body growth.Acta Endocrinol 1982; 99: 24–30.

    PubMed  CAS  Google Scholar 

  20. Clark RG, Jansson JO, Isaksson O, Robinson ICAF. Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats.J Endocrinol 1985; 104: 53–61.

    PubMed  CAS  Google Scholar 

  21. Sandahl Christiansen J, Orskov H, Binder C, Kastrup KW. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.Acta Endocrinol 1983; 102: 6–10.

    Google Scholar 

  22. Kastrup KW, Sandahl Christiansen J, Koch Andersen J, Orskov H. Increased growth rate following transfer to daily s.c. administration from three weekly i.m. injections of hGh in growth hormone deficient children.Acta Endocrinol 1983; 104: 148–152.

    PubMed  CAS  Google Scholar 

  23. Albertsson-Wikland K, Westphal O, Westgren U. Daily subcutaneous administration of human growth hormone in growth hormone deficient children.Acta Paediatr Scand 1986; 75: 89–97.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Subdivision Endocrinology, Erasmus University and University Hospital, Rotterdam, The Netherlands

    Muinck De Keizer-Schrama S.M.P.F.

  2. Sophia Children’s Hospital, P.O. Box 70029, 3000 LL, Rotterdam, The Netherlands

    Muinck De Keizer-Schrama S.M.P.F.

Authors
  1. Muinck De Keizer-Schrama S.M.P.F.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Keizer-Schrama, M. Optimization of growth hormone therapy in growth hormone deficient children. Indian J Pediatr 58 (Suppl 5), 17–21 (1991). https://doi.org/10.1007/BF02750979

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02750979

Keywords

Search

Navigation